A detailed history of M&T Bank Corp transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 17,381 shares of SWTX stock, worth $618,589. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,381
Previous 17,381 -0.0%
Holding current value
$618,589
Previous $556,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$32.04 - $42.76 $5,222 - $6,969
163 Added 0.95%
17,381 $556,000
Q2 2024

Jul 31, 2024

SELL
$36.06 - $47.62 $1,803 - $2,381
-50 Reduced 0.29%
17,218 $648,000
Q1 2024

May 07, 2024

SELL
$36.5 - $52.5 $114,062 - $164,062
-3,125 Reduced 15.32%
17,268 $849,000
Q4 2023

Feb 06, 2024

SELL
$18.94 - $37.24 $2,178 - $4,282
-115 Reduced 0.56%
20,393 $744,000
Q3 2023

Nov 02, 2023

SELL
$23.12 - $31.38 $1,710 - $2,322
-74 Reduced 0.36%
20,508 $474,000
Q2 2023

Aug 09, 2023

BUY
$23.15 - $32.71 $5,231 - $7,392
226 Added 1.11%
20,582 $539,000
Q4 2022

Feb 13, 2023

BUY
$21.73 - $28.72 $218,799 - $289,181
10,069 Added 97.88%
20,356 $529,000
Q4 2022

Feb 13, 2023

SELL
$21.73 - $28.72 $218,799 - $289,181
-10,069 Reduced 49.46%
10,287 $267,000
Q3 2022

Nov 14, 2022

SELL
$24.1 - $39.66 $133,176 - $219,161
-5,526 Reduced 21.35%
20,356 $580,000
Q2 2022

Aug 05, 2022

BUY
$18.36 - $60.07 $392,096 - $1.28 Million
21,356 Added 471.85%
25,882 $638,000
Q1 2022

May 09, 2022

BUY
$48.97 - $65.46 $35,405 - $47,327
723 Added 19.01%
4,526 $255,000
Q4 2021

Feb 07, 2022

BUY
$53.3 - $75.84 $11,033 - $15,698
207 Added 5.76%
3,803 $236,000
Q1 2021

May 06, 2021

SELL
$65.1 - $93.59 $197,513 - $283,952
-3,034 Reduced 45.76%
3,596 $264,000
Q4 2020

Feb 12, 2021

BUY
$48.36 - $77.92 $822 - $1,324
17 Added 0.26%
6,630 $481,000
Q3 2020

Nov 06, 2020

BUY
$36.14 - $51.99 $52,908 - $76,113
1,464 Added 28.43%
6,613 $315,000
Q2 2020

Jul 29, 2020

BUY
$22.98 - $48.57 $118,324 - $250,086
5,149 New
5,149 $216,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.22B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.